Publications by authors named "Yangcan Ming"

Claim this Profile
E
Exploring the impact of nano platinum-hydrogen saline on oxygen-induced retinopathy in neonatal rats.
Yangcan Ming, Wanyi Xu, Zhe Yang, Zi Wang, Na Wang

J Matern Fetal Neonatal Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ROS-Responsive Cationic Polymers with Intrinsic Anti-Inflammatory Activity for Intracellular Protein Delivery.
Yongming Wang, Yangcan Ming, Zhichao Yu, Zhenjin Xu, Minglang Zou

Biomacromolecules· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colon-targeted hydroxyethyl starch-curcumin microspheres with high loading capacity ameliorate ulcerative colitis via alleviating oxidative stress, regulating inflammation, and modulating gut microbiota.
Da Huang, Yongming Wang, Chenlan Xu, Minglang Zou, Yangcan Ming

Int J Biol Macromol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The first case of intellectual disability caused by novel compound heterozygosity for NUDT2 variants.
Bo Bi, Xiaohong Chen, Shan Huang, Min Peng, Weiyue Gu, Yangcan Ming

BMC Pediatr· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectious mononucleosis in children and differences in biomarker levels and other features between disease caused by Epstein-Barr virus and other pathogens: a single-center retrospective study in China.
Yangcan Ming, Shengnan Cheng, Zhixin Chen, Wen Su, Shuangyan Lu

PeerJ· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk prediction of dysthyroid optic neuropathy based on CT imaging features combined the bony orbit with the soft tissue structures.
Shengnan Cheng, Yangcan Ming, Mang Hu, Yan Zhang, Fagang Jiang

Front Med (Lausanne)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colon-targeted oral nanoparticles based on ROS-scavenging hydroxyethyl starch-curcumin conjugates for efficient inflammatory bowel disease therapy.
Chenlan Xu, Shuting Chen, Cuiping Chen, Yangcan Ming, Jiahao Du

Int J Pharm· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis